Ratings changes for Oncternal Therapeutics, Lyra Therapeutics, Atrion, Geron, Aurora Innovation, Charter Communications, Arbutus Biopharma and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial. Unsubscribe.
VIEW MY PORTFOLIO
September 12th, 2023
The A.I. Trend Has These 7 Stocks Set To Soar (ad)
Making profits in the stock market depends on making your entry at the right time. The time is NOW to get into A.I. Artificial Intelligence is turning into one of the most popular trends this year, and it has only just begun. (**By clicking the link you are subscribing to the The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here)
The dot-com crash… the housing bubble… the COVID crash… but we've still never seen anything like what's coming for artificial intelligence in as little as three months. It's called the Singularity – and it refers to the exact millisecond when AI breaks free from its shackles to grow BILLIONS of times more powerful than humans.
AngloGold Ashanti (NYSE:AU) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $22.00 price target on the stock, up previously from $19.00. This represents a 23.9% upside from the current price of $17.75.
Cintas (NASDAQ:CTAS) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $580.00 price target on the stock, up previously from $523.00. This represents a 14.3% upside from the current price of $507.34.
CVS Health (NYSE:CVS) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $80.00 price target on the stock. This represents a 13.4% upside from the current price of $70.52.
BRP (NASDAQ:DOOO) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $94.00 price target on the stock, up previously from $81.00. They noted that the move was a valuation call. This represents a 24.8% upside from the current price of $75.31.
Equinox Gold (NYSEAMERICAN:EQX) was upgraded by analysts at Royal Bank of Canada from an "underperform" rating to a "sector perform" rating.The current price is $4.90.
Geron (NASDAQ:GERN) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $4.00 price target on the stock. This represents a 71.7% upside from the current price of $2.33.
Gjensidige Forsikring ASA (OTCMKTS:GJNSY) was upgraded by analysts at Nordea Equity Research from a "hold" rating to a "buy" rating.The current price is $15.18.
Galaxy Entertainment Group (OTCMKTS:GXYEY) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating.
HSBC (NYSE:HSBC) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating.The current price is $38.00.
IAMGOLD (NYSE:IAG) (TSE:IMG) was upgraded by analysts at Royal Bank of Canada from an "underperform" rating to a "sector perform" rating. They now have a $2.75 price target on the stock, up previously from $1.75. This represents a 17.0% upside from the current price of $2.35.
Ipsen (OTCMKTS:IPSEY) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.The current price is $32.61.
K92 Mining (OTCMKTS:KNTNF) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating.The current price is $4.49.
PICC Property and Casualty (OTCMKTS:PPCCY) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating.The current price is $30.81.
Tencent (OTCMKTS:TCEHY) was upgraded by analysts at Investec from a "sell" rating to a "hold" rating.The current price is $41.20.
Watches of Switzerland Group (OTC:WOSGF) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating.The current price is $7.40.
Avantax (NASDAQ:AVTA) was downgraded by analysts at Barrington Research from an "outperform" rating to a "market perform" rating.The current price is $25.55.
China Life Insurance (OTCMKTS:CILJF) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating.The current price is $1.53.
Crescent Point Energy (NYSE:CPG) (TSE:CPG) was downgraded by analysts at TD Securities to a "buy" rating.The current price is $8.41.
Enphase Energy (NASDAQ:ENPH) was downgraded by analysts at Truist Financial Co. from a "buy" rating to a "hold" rating. They now have a $135.00 price target on the stock, down previously from $210.00. This represents a 9.7% upside from the current price of $123.09.
Earthstone Energy (NYSE:ESTE) was downgraded by analysts at Capital One Financial Co. from an "overweight" rating to an "equal weight" rating. They now have a $20.00 price target on the stock. This represents a 2.4% downside from the current price of $20.50.
First National (NASDAQ:FXNC) was downgraded by analysts at Janney Montgomery Scott from a "buy" rating to a "neutral" rating. They now have a $19.00 price target on the stock. They noted that the move was a valuation call. This represents a 1.6% upside from the current price of $18.70.
Henkel AG & Co. KGaA (OTCMKTS:HENKY) was downgraded by analysts at BNP Paribas from an "outperform" rating to a "neutral" rating.The current price is $17.21.
Osisko Development (NYSE:ODV) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating.The current price is $2.88.
Orthofix Medical (NASDAQ:OFIX) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating.The current price is $13.81.
Orthofix Medical (NASDAQ:OFIX) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.The current price is $13.81.
Oracle (NYSE:ORCL) was downgraded by analysts at Monness Crespi & Hardt from a "buy" rating to a "neutral" rating.The current price is $110.93.
Pennon Group (OTCMKTS:PEGRF) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating.The current price is $7.66.
Perion Network (NASDAQ:PERI) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $30.35.
Reckitt Benckiser Group (OTCMKTS:RBGLY) was downgraded by analysts at BNP Paribas from a "neutral" rating to an "underperform" rating.The current price is $14.55.
RTX (NYSE:RTX) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $75.00 price target on the stock, down previously from $100.00. This represents a 1.1% upside from the current price of $74.21.
RTX (NYSE:RTX) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating. They now have a $82.00 price target on the stock, down previously from $105.00. This represents a 10.5% upside from the current price of $74.21.
Sands China (OTCMKTS:SCHYY) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating.The current price is $31.80.
Sight Sciences (NASDAQ:SGHT) was downgraded by analysts at William Blair from an "outperform" rating to a "market perform" rating.The current price is $3.25.
Sight Sciences (NASDAQ:SGHT) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $4.50 price target on the stock, down previously from $10.00. This represents a 38.5% upside from the current price of $3.25.
Severn Trent (OTCMKTS:STRNY) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating.The current price is $31.65.
Hostess Brands (NASDAQ:TWNK) was downgraded by analysts at Consumer Edge from an "overweight" rating to an "equal weight" rating.The current price is $33.47.
Hostess Brands (NASDAQ:TWNK) was downgraded by analysts at Stephens from an "overweight" rating to an "equal weight" rating.The current price is $33.47.
Limited Time Only - Get MarketBeat All Access for Just $99.00 (ad)
Feel like you're always falling behind the market? Get access to professional investing tools for less than the cost of a Netflix subscription. Upgrade to MarketBeat All Access today for just $99.00 (normally $399.00). Get our top stock picks, best-in-class research tools, real-time alerts, proprietary research reports, and much more.
Ambrx Biopharma (NYSE:AMAM) is now covered by analysts at BTIG Research. They set a "buy" rating and a $26.00 price target on the stock. This represents a 121.1% upside from the current price of $11.76.
Antofagasta (OTCMKTS:ANFGF) is now covered by analysts at HSBC Holdings plc. They set a "reduce" rating on the stock.The current price is $19.08.
Aurora Innovation (NASDAQ:AUR) is now covered by analysts at Evercore ISI. They set an "inline" rating and a $4.00 price target on the stock. This represents a 17.6% upside from the current price of $3.40.
BeiGene (NASDAQ:BGNE) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $259.00 price target on the stock. This represents a 25.1% upside from the current price of $207.02.
BSR Real Estate Investment Trust (OTCMKTS:BSRTF) is now covered by analysts at TD Securities. They set a "buy" rating on the stock.The current price is $12.03.
Carbios SAS (OTCMKTS:COOSF) is now covered by analysts at Berenberg Bank. They set a "buy" rating on the stock.The current price is $26.35.
CTP (OTCMKTS:CTPVF) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating on the stock.
Jet2 (OTCMKTS:DRTGF) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.The current price is $13.41.
Endeavor Group (NYSE:EDR) is now covered by analysts at TD Cowen. They set an "outperform" rating and a $28.00 price target on the stock. This represents a 25.8% upside from the current price of $22.26.
Epiroc AB (publ) (OTCMKTS:EPOKY) is now covered by analysts at Barclays PLC. They set an "underweight" rating on the stock.The current price is $19.41.
Gain Therapeutics (NASDAQ:GANX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $10.00 price target on the stock. This represents a 174.0% upside from the current price of $3.65.
Global Blue Group (NYSE:GB) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $8.00 price target on the stock. This represents a 40.8% upside from the current price of $5.68.
Genelux (NASDAQ:GNLX) is now covered by analysts at Maxim Group. They set a "buy" rating and a $40.00 price target on the stock. This represents a 85.1% upside from the current price of $21.61.
GitLab (NASDAQ:GTLB) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $62.00 price target on the stock. This represents a 16.5% upside from the current price of $53.22.
GitLab (NASDAQ:GTLB) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $62.00 price target on the stock. This represents a 16.5% upside from the current price of $53.22.
Metso Oyj (OTCMKTS:OUKPY) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.The current price is $5.54.
Rexford Industrial Realty (NYSE:REXR) is now covered by analysts at Scotiabank. They set a "sector perform" rating and a $59.00 price target on the stock. This represents a 12.2% upside from the current price of $52.57.
Sandvik AB (publ) (OTCMKTS:SDVKY) is now covered by analysts at Barclays PLC. They set an "underweight" rating on the stock.The current price is $18.77.
Endeavor Operating (NYSE:TKO) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $132.00 price target on the stock.
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:
Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeat's free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com or leave us a voicemail at (844) 978-6257.
Post a Comment
Post a Comment